The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
This grant supports the development of in vitro and/or ex vivo assays to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. Part of the Innovation Grants to Nurture Initial Translational Efforts (IGNITE), its goal is to advance projects to a stage where they can enter the Blueprint Neurotherapeutics Network (BPN) or similar translational programs.